Profitelligence Profitelligence · Filing Ledger Open TWST research →

Form 8-K · Current Report · Filed 2024-02-07

Twist Bioscience Shareholders Approve Director Elections and NEO Compensation

At the 2024 Annual Meeting of Stockholders held on February 6, 2024, Twist Bioscience Corporation's shareholders approved the election of two directors, the compensation of the named executive officers on a non-binding basis, and ratified the appointment of Ernst & Young LLP as the independent registered accounting firm for the fiscal year ending September 30, 2024.

Filer
Twist Bioscience Corporation TWST · NASDAQ
Filed
Accession
0001104659-24-011607
CIK
0001581280
Signal
Medium impactHealthcare

Items reported

Item 5.07

Submission of Matters to a Vote of Security Holders

Director Elections Results Equity Plan Approved Say-on-Pay Approved

Market reaction

Close before filing

$36.97

Next session

-1.2%

Since filing

+320.8%

Latest close

$155.56

What happened, not what will happen — closing prices around the filing date.

About Twist Bioscience Corporation

Twist Bioscience Corporation is a pioneering biotechnology firm revolutionizing the field of synthetic DNA. The company's primary function is to produce synthetic DNA using a proprietary silicon-based manufacturing platform, enabling the creation of high-quality, accurate, and cost-effective DNA at scale. Twist Bioscience's innovations impact multiple sectors, including pharmaceuticals, industrial chemicals, agriculture, and data storage, offering transformative solutions in drug development, crop protection, and genomic research. By leveraging its proprietary DNA synthesis platform, Twist Bioscience plays a vital role in the broader biotechnology market, facilitating advancements that drive progress in personalized medicine and sustainable practices. With its cutting-edge technology, the company provides researchers and businesses with access to a wide array of DNA products and solutions essential for scientific discovery and technological innovation, underpinning its significance in the expanding biotech landscape.

Exchange NASDAQ Industry Diagnostics & Research Company website ↗

Never miss another TWST filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts